Skip to main content
Premium Trial:

Request an Annual Quote

He's Got the Money to Do Something About It

Based on a genome scan from his wife's company, 23andMe, Google's Sergey Brin learned that he has a mutation of the LRRK2 gene that accounts for a good portion of familial Parkinson's disease. (Brin's mother, Eugenia, has Parkinson's and her genome scan shows the same mutation.) On his blog, called too, Brin writes that the implications of this finding are not completely clear, though he seems to have a higher chance of developing Parkinson's than the average person. He also says that he can now take measures to reduce his risk and to support Parkinson's research.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.